Les troubles de la déglutition sont-ils possibles ?
Oui, des troubles de la déglutition peuvent survenir, augmentant le risque de pneumonie par aspiration.
Troubles de la déglutitionPneumonie par aspiration
#3
Y a-t-il un risque accru de démence ?
Oui, les angiopathies des ganglions de la base augmentent le risque de démence vasculaire.
Démence vasculaireComplications neurologiques
#4
Les chutes sont-elles une préoccupation ?
Oui, les troubles de l'équilibre augmentent le risque de chutes et de blessures graves.
ChutesTroubles de l'équilibre
#5
Peut-on développer des troubles psychiatriques ?
Oui, des troubles comme la dépression ou l'anxiété peuvent survenir en raison de la maladie.
Troubles psychiatriquesDépression
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'hyperlipidémie.
HypertensionDiabète
#2
L'âge est-il un facteur de risque ?
Oui, le risque d'angiopathies augmente avec l'âge, surtout après 65 ans.
Âge avancéFacteurs de risque
#3
Le diabète influence-t-il le risque ?
Oui, le diabète mal contrôlé augmente le risque d'angiopathies cérébrales.
DiabèteMaladies vasculaires cérébrales
#4
Le stress a-t-il un impact ?
Oui, le stress chronique peut contribuer à des problèmes cardiovasculaires et cérébraux.
StressSanté mentale
#5
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents familiaux de maladies vasculaires augmentent le risque d'angiopathies.
Antécédents familiauxFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Angiopathies des ganglions de la base : Questions médicales les plus fréquentes",
"headline": "Angiopathies des ganglions de la base : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Angiopathies des ganglions de la base : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-20",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Angiopathies des ganglions de la base"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Angiopathies intracrâniennes",
"url": "https://questionsmedicales.fr/mesh/D002561",
"about": {
"@type": "MedicalCondition",
"name": "Angiopathies intracrâniennes",
"code": {
"@type": "MedicalCode",
"code": "D002561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.253"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Angiopathies des ganglions de la base",
"alternateName": "Basal Ganglia Cerebrovascular Disease",
"code": {
"@type": "MedicalCode",
"code": "D020144",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Clara Rodriguez-Sabate",
"url": "https://questionsmedicales.fr/author/Clara%20Rodriguez-Sabate",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Ingrid Morales",
"url": "https://questionsmedicales.fr/author/Ingrid%20Morales",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain."
}
},
{
"@type": "Person",
"name": "Manuel Rodriguez",
"url": "https://questionsmedicales.fr/author/Manuel%20Rodriguez",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es."
}
},
{
"@type": "Person",
"name": "Huiling Tan",
"url": "https://questionsmedicales.fr/author/Huiling%20Tan",
"affiliation": {
"@type": "Organization",
"name": "Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Taiwan Controlled Substances Database.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36031487",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jfma.2022.06.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of clinical decision support on controlled substance prescribing.",
"datePublished": "2023-10-20",
"url": "https://questionsmedicales.fr/article/37864226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12911-023-02314-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Associations of clinical personnel characteristics and controlled substance prescribing practices.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37134110",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jom-2022-0234"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent Advances in the Development of Portable Electrochemical Sensors for Controlled Substances.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/36991851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23063140"
}
},
{
"@type": "ScholarlyArticle",
"name": "Theft of Controlled Substances in Long-Term Care Homes: An Exploratory Study.",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36691366",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/07334648231153731"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Angiopathies intracrâniennes",
"item": "https://questionsmedicales.fr/mesh/D002561"
},
{
"@type": "ListItem",
"position": 5,
"name": "Angiopathies des ganglions de la base",
"item": "https://questionsmedicales.fr/mesh/D020144"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Angiopathies des ganglions de la base - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Angiopathies des ganglions de la base",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Angiopathies des ganglions de la base",
"description": "Comment diagnostiquer une angiopathie des ganglions de la base ?\nQuels tests sont utilisés pour évaluer la fonction cérébrale ?\nQuels signes cliniques indiquent une angiopathie ?\nL'angiographie est-elle utile dans le diagnostic ?\nQuels sont les critères de diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Angiopathies des ganglions de la base",
"description": "Quels sont les symptômes courants des angiopathies ?\nPeut-on avoir des symptômes sans AVC ?\nLes troubles de la mémoire sont-ils fréquents ?\nY a-t-il des signes d'alerte précoce ?\nLes troubles de la parole sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Angiopathies des ganglions de la base",
"description": "Comment prévenir les angiopathies des ganglions de la base ?\nLe contrôle de la pression artérielle est-il important ?\nLe tabagisme influence-t-il le risque ?\nUne alimentation riche en oméga-3 est-elle bénéfique ?\nL'exercice physique aide-t-il à prévenir ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Angiopathies des ganglions de la base",
"description": "Quels traitements sont disponibles pour cette condition ?\nLa chirurgie est-elle une option ?\nQuels médicaments sont souvent prescrits ?\nLa rééducation est-elle nécessaire ?\nY a-t-il des traitements non médicamenteux ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Angiopathies des ganglions de la base",
"description": "Quelles complications peuvent survenir ?\nLes troubles de la déglutition sont-ils possibles ?\nY a-t-il un risque accru de démence ?\nLes chutes sont-elles une préoccupation ?\nPeut-on développer des troubles psychiatriques ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Angiopathies des ganglions de la base",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLe diabète influence-t-il le risque ?\nLe stress a-t-il un impact ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D020144?mesh_terms=Controlled+Substances#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une angiopathie des ganglions de la base ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie cérébrale, comme l'IRM ou le scanner, et l'évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la fonction cérébrale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests neuropsychologiques et des évaluations neurologiques sont utilisés pour évaluer la fonction."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une angiopathie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles moteurs, des troubles de la parole ou des changements cognitifs peuvent indiquer une angiopathie."
}
},
{
"@type": "Question",
"name": "L'angiographie est-elle utile dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'angiographie peut aider à visualiser les vaisseaux sanguins et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents médicaux, des symptômes cliniques et des résultats d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des angiopathies ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la motricité, des troubles de l'équilibre et des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans AVC ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent apparaître progressivement sans événement AVC aigu, souvent liés à une ischémie chronique."
}
},
{
"@type": "Question",
"name": "Les troubles de la mémoire sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de la mémoire peuvent survenir en raison de l'atteinte des ganglions de la base."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte précoce ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des maux de tête fréquents ou des changements d'humeur peuvent être des alertes."
}
},
{
"@type": "Question",
"name": "Les troubles de la parole sont-ils possibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des difficultés d'élocution peuvent survenir en raison de l'atteinte des zones cérébrales impliquées."
}
},
{
"@type": "Question",
"name": "Comment prévenir les angiopathies des ganglions de la base ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un mode de vie sain, incluant une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le contrôle de la pression artérielle est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir une pression artérielle normale est crucial pour réduire le risque d'angiopathies."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque d'angiopathies cérébrales et d'autres maladies vasculaires."
}
},
{
"@type": "Question",
"name": "Une alimentation riche en oméga-3 est-elle bénéfique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en oméga-3 peut contribuer à la santé vasculaire et cérébrale."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier aide à maintenir une bonne circulation sanguine et à réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour cette condition ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments pour contrôler les symptômes et la rééducation fonctionnelle."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie peut être envisagée dans certains cas, notamment pour traiter des anomalies vasculaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont souvent prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticoagulants, des antihypertenseurs et des médicaments pour les symptômes neurologiques peuvent être prescrits."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation est souvent essentielle pour améliorer la fonction motrice et cognitive."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme la thérapie occupationnelle et la stimulation cognitive peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des AVC, des troubles cognitifs sévères et des incapacités fonctionnelles."
}
},
{
"@type": "Question",
"name": "Les troubles de la déglutition sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la déglutition peuvent survenir, augmentant le risque de pneumonie par aspiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de démence ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les angiopathies des ganglions de la base augmentent le risque de démence vasculaire."
}
},
{
"@type": "Question",
"name": "Les chutes sont-elles une préoccupation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles de l'équilibre augmentent le risque de chutes et de blessures graves."
}
},
{
"@type": "Question",
"name": "Peut-on développer des troubles psychiatriques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la dépression ou l'anxiété peuvent survenir en raison de la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'angiopathies augmente avec l'âge, surtout après 65 ans."
}
},
{
"@type": "Question",
"name": "Le diabète influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète mal contrôlé augmente le risque d'angiopathies cérébrales."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à des problèmes cardiovasculaires et cérébraux."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque d'angiopathies."
}
}
]
}
]
}
Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain.
Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Department of Psychiatry, Getafe University Hospital, Madrid, Spain.
Publications dans "Angiopathies des ganglions de la base" :
Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain.
Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Publications dans "Angiopathies des ganglions de la base" :
Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es.
Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. mrdiaz@ull.edu.es.
Publications dans "Angiopathies des ganglions de la base" :
Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford, UK.
Publications dans "Angiopathies des ganglions de la base" :
Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, Russell Square House, London WC1B 5EH, UK.
Max Planck UCL Centre for Computational Psychiatry and Ageing Research, UCL Queen Square Institute of Neurology, University College London, Russell Square House, London WC1B 5EH, UK.
Publications dans "Angiopathies des ganglions de la base" :
New psychoactive substances (NPS) have increasingly been illegally synthesized and used around the world in recent years. Due to the large volume and the variety of NPS, most do not have sufficient in...
Prescription drug overdose and misuse has reached alarming numbers. A persistent problem in clinical care is lack of easy, immediate access to all relevant information at the actionable time. Prescrib...
This study was conducted at a large multi-center healthcare system, using data from the electronic health record. A prospective observational study was performed as clinical decision support (CDS) int...
An alert was triggered in 23.5% of encounters with a prescription (n = 555,626). The prescriber decision was influenced in 18.1% of these encounters (n = 100,301). As the number of risk factors increa...
The delivery of evidence-based, patient-specific information had an influence on the final prescription in nearly 1 in 5 encounters. Our intervention was sustained with minimal prescriber fatigue over...
Over 68,000 deaths were attributed to opioid-related overdose in 2020. Evaluative studies have shown that states that utilized Prescription Drug Monitoring Program (PDMP) systems have decreased opioid...
This study aims to assess prescribing behaviors by physicians in 2021 based on four demographics utilizing the National Electronic Health Record System (NEHRS): physician's age, sex, specialty, and de...
We performed a cross-sectional study of the 2021 NEHRS to determine the relationship between physician characteristics and PDMP use on opioid-prescribing behaviors. Differences between groups were mea...
Compared to female physicians, male physicians were more likely to alter their original prescription to reduce morphine milligram equivalents (MMWs) prescribed for a patient (AOR: 1.60; CI: 1.06-2.39;...
Our results showed a statistically significant difference between specialty category and frequency of prescribing controlled substances. After checking the PDMP, male physicians were more likely to al...
This review article summarizes recent achievements in developing portable electrochemical sensing systems for the detection and/or quantification of controlled substances with potential on-site applic...
The theft of controlled substances has been studied in the community and healthcare settings including hospitals, pharmacies, hospice, and pain clinics. However, research on these thefts in long-term ...
This case report demonstrates the impact of different sampling sites on the quantification of narcotic substances. In 2020, officers secured a syringe containing a light-yellow paste-like substance, f...
A significant concern in the policy landscape of the U.S. opioid crisis is whether supply-side controls can reduce opioid prescribing without harmful substitution. We consider an unstudied policy: the...
The shift from prescription to illicit drugs involved in drug poisoning deaths raises questions about the current utility of prescription drug monitoring program (PDMP) data to inform drug poisoning (...
The study used linked death certificates and PDMP data for 2,248 Kentucky resident drug poisoning deaths in 2021. Death certificate literal text analysis identified drugs mentioned with involvement (D...
Overall, 25.5% of all decedents had dispensed CS in the month before fatal drug poisoning. Over 80% of decedents were dispensed opioid(s) since 2008; the percentage was similar regardless of opioid in...
Overall, concordance between CS dispensing history and the drugs involved in poisoning deaths was low, suggesting a need to reevaluate the complex relationships between prescription medication exposur...
Lemborexant (LEM) is a dual orexin receptor antagonist (DORA) approved in multiple countries including the USA, Japan, Canada, Australia, and several Asian countries for the treatment of insomnia in a...
This review discusses data for LEM relevant to each of the 8 factors of the United States Controlled Substances Act....
LEM did not demonstrate abuse potential in nonclinical testing and was associated with a low incidence of abuse-related adverse events in clinical study participants with insomnia disorder. Similar to...
LEM, similar to most other prescription insomnia medications, was placed into Schedule IV. However, LEM and other drugs in the DORA class may have a lower potential for abuse as suggested by real-worl...
Pre-injury drug use is a key contributor to traumatic injury. However, limited research has examined trends and predictors of controlled substance-related trauma. The present study aims to provide bet...